Impact of metformin on the clinical and metabolic parameters of women with polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials
Its ability to promote proper tissue regeneration, not just scar formation, makes the difference
In a meta-analysis 6 of eight trials with 60080 patients (ELIXA, LEADER, SUSTAIN-6, EXSCEL, Harmony Outcomes, REWIND, PIONEER 6, and AMPLITUDE-O) , treatment with a GLP-1 receptor agonist led to a 14% relative risk reduction in three-point MACE (HR 086 [95% CI 080093]
New Research: Muscle Loss and Metabolic Impact A July 2025 study presented at ENDO 2025 and covered by ScienceDaily found that women on GLP-1 drugs like Ozempic may lose up to 40% of their weight from muscle mass, not just fat
My over active imagination is conjuring up pictures of anaphylactic shocks, even though I have had the B12 injections from doctor before